| Product NDC: | 55566-0302 |
| Proprietary Name: | ACTHREL |
| Non Proprietary Name: | corticorelin ovine triflutate |
| Active Ingredient(s): | 100 ug/2mL & nbsp; corticorelin ovine triflutate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55566-0302 |
| Labeler Name: | Ferring Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020162 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960523 |
| Package NDC: | 55566-0302-1 |
| Package Description: | 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1) |
| NDC Code | 55566-0302-1 |
| Proprietary Name | ACTHREL |
| Package Description | 2 mL in 1 VIAL, SINGLE-DOSE (55566-0302-1) |
| Product NDC | 55566-0302 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | corticorelin ovine triflutate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19960523 |
| Marketing Category Name | NDA |
| Labeler Name | Ferring Pharmaceuticals Inc. |
| Substance Name | CORTICORELIN OVINE TRIFLUTATE |
| Strength Number | 100 |
| Strength Unit | ug/2mL |
| Pharmaceutical Classes |